KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Return on Capital Employed (2016 - 2025)

NovoCure (NVCR) has disclosed Return on Capital Employed for 11 consecutive years, with 0.18% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 18.0% to 0.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.18% through Dec 2025, up 18.0% year-over-year, with the annual reading at 0.19% for FY2025, 20.0% up from the prior year.
  • Return on Capital Employed hit 0.18% in Q4 2025 for NovoCure, up from 0.33% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.04% in Q1 2021 to a low of 0.36% in Q4 2024.
  • Historically, Return on Capital Employed has averaged 0.17% across 5 years, with a median of 0.18% in 2024.
  • Biggest five-year swings in Return on Capital Employed: decreased -16bps in 2023 and later grew 18bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.04% in 2021, then crashed by -95bps to 0.09% in 2022, then tumbled by -175bps to 0.24% in 2023, then tumbled by -49bps to 0.36% in 2024, then soared by 50bps to 0.18% in 2025.
  • Business Quant data shows Return on Capital Employed for NVCR at 0.18% in Q4 2025, 0.33% in Q3 2025, and 0.35% in Q2 2025.